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Case Report
Lymphoepithelioma-like carcinoma of urinary bladder: (LELCA)
Nausheen Yaqoob1, Naila Kayani1, Jaipal Piryani2, Mohammad Nasir Sulaiman2, Sheema H. Hasan1
Departments of Surgery1 and Pathology and Microbiology2, The Aga Khan University Hospital, Karachi.
Abstract
Lymphoepithelioma-like carcinoma of the bladder
(LELCA) is an uncommon neoplasm of the urinary bladder
and up till now only 49 cases have been reported in the
English literature. It is imperative to distinguish between
lymphoepithelioma-like carcinoma and malignant lym-
phoma as primary bladder lymphoma is extremely rare. We
report a case of a 55 year old lady who presented with the
complaint of burning micturition and gross hematuria for
the past 5 months. There were no other known co-morbids.
Pelvic ultrasound was normal. Cystoscopy showed a 4x4
cm sessile mass in the bladder. Histopathological examina-
tion was consistent with the diagnosis of lymphoepithe-
lioma like carcinoma of the urinary bladder.
Introduction
Lymphoepithelioma-like carcinoma of the bladder
(LELCA) is an uncommon neoplasm of the urinary bladder and
till now only 49 cases have been reported in the English litera-
ture.1 It is a malignant epithelial neoplasm characterized by
indistinct cytoplasmic boundries and a syncitial growth pattern.
The stroma is densely infiltrated by lymphocytes. About 90% of
the malignant tumors of the bladder are urothelial carcinomas
(UCs). The remaining 10% correspond to other types of carci-
nomas, sarcomas or other uncommon tumors.1
Case Report
A 55 year old lady presented with the complaint of
burning micturition and gross hematuria for the past 5
months. She had past medical history of sphenoid wing
meningioma for which she was operated two years back with
an uneventful recovery. There were no other known co-mor-
bids. There was no history of exposure to carcinogenic mate-
rial or cigarette smoking. Pelvic ultrasound was normal.
Cystoscopy showed a 4x4 cm sessile mass in the right super-
olateral wall of the bladder invading deep into the bladder
muscle. The whole tumor was resected endoscopically. The
specimen was sent for histopathology. Gross examination
showed multiple irregular fragments of tissue measuring 5
cm in aggregate. Microscopically the tumor was composed
of sheets and clusters of large epithelial cells having moder-
ate amount of cytoplasm. The lymphoid background consist-
Figure 1. H & E showing sheets of large epithelial cells having moderate amount of cytoplasm.
The lymphoid background consisted of mature lymphocytes mixed with plasma cells (Mag 10x).
Figure 2. High power magnification showing round to oval vesicular nuclei with prominent nucle-
oli. Note mitotic figures.
Figure 3. The tumour cells are strongly positive for epithelial marker CK MNFs.
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of mature lymphocytes mixed with plasma cells. (Figure 1)
Abundant mitotic figures were present. The nuclei were
round to oval and vesicular with prominent nucleoli. (Figure
2) Glycogen was identified in the epithelial cells. The tumor
cells were strongly positive for epithelial markers (CK MNF
(Figure 3), CK cam 5.2, CK AE1/AE3 and negative for lym-
phoid markers (LCA CD45;RO, Pan B;CD20 and CD79a,
Pan T; UCHL1) and vimentin. Protein p53 was positive in
80-85% of the nuclei of epithelial cells and negative in the
lymphoid cells. Overlying urothelium showed no dysplasia.
The tumor was deeply infiltrating into the detrusor muscle.
A diagnosis of lymphoepithelioma like carcinoma of the uri-
nary bladder was made.
Discussion
Lymphoepithelioma-like carcinoma of the bladder
was described by Zuckerberg et al2 in 1991 and till now 49
cases have been published. They represent 0.4% and 1.3%
of the bladder carcinomas.3 It is imperative to distinguish
between lymphoepithelioma-like carcinoma and malig-
nant lymphoma as primary bladder lymphoma is extreme-
ly rare.4 LELC was originally described in nasopharynx,
but it has also been found in other organs, such as salivary
gland, thymus, uterine cervix, skin, lung, stomach, oral
cavity, breast, vagina, trachea and larynx and, rarely, in
other areas of urinary tract (renal pelvis, ureter).5 LELCA
are usually small tumors (0.9-5 cm)5 and most of them
present a clinical onset with hematuria, as we described in
our cases. The mean age at diagnosis is 69 years. Of the
patient population 69% were men3 however both of our
patients were females.
Most lymphoepithelioma-like carcinomas are not
associated with Epstein-Barr virus, except those of the
nasopharynx6 Iezzoni et al examined 11 cases for EBV by
RNA ISH EBER and none showed EBER transcripts.7
Expression of p53 is commonly seen in Ucs and this
positive phenotype is more common in high grade and
advanced Ucs. Izquierdo-Garcia et al has studied p53 protein
expression in LELCA and has seen intense reaction of p53 in
90-95% of their nuclei, however despite this finding and
despite that they have been treated with preservation of the
bladder, they have followed a good clinical course.1 In our
cases p53 protein expression was seen in 80-85% of the
nuclei.  Lymphoepithelioma-like carcinoma is sensitive to cis-
platin based chemotherapy8 and radiotherapy, reviewing the
literature and evaluating the present results, a combination of
TURBT and adjuvant chemotherapy is probably effective
against LELCA, avoiding radical cystectomy.
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